Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery

The number of agents that are potentially effective in the adjuvant treatment of locally advanced resectable colon cancer is increasing. Consequently, it is important to ascertain which subgroups of patients will benefit from a specific treatment. Despite more than two decades of research into the m...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Tejpar, Sabine, Bertagnolli, Monica, Bosman, Fred, Lenz, Heinz-Joseph, Garraway, Levi, Waldman, Frederic, Warren, Robert, Bild, Andrea, Collins-Brennan, Denise, Hahn, Hejin, Harkin, D. Paul, Kennedy, Richard, Ilyas, Mohammad, Morreau, Hans, Proutski, Vitali, Swanton, Charles, Tomlinson, Ian, Delorenzi, Mauro, Fiocca, Roberto, Van Cutsem, Eric, Roth, Arnaud
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AlphaMed Press 2010
Pynciau:
Academia-Pharma Intersect
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227961/
https://ncbi.nlm.nih.gov/pubmed/20350999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0233
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg